Enamine is a leading supplier of fine chemicals worldwide. Screening compounds are in the main focus of Enamine production activity. Key products of Enamine also include building blocks, targeted libraries and focused libraries. We provide fully integrated smart chemistry solutions for drug design and development: custom synthesis, contract research, lead generation and optimization programs.
Currently Enamine offers its customers one of the largest and the most chemically diverse proprietary screening collection of organic compounds in the world:
---over 1 200 000 Screening Compounds in-stock
---over 26 000 proprietary Building Blocks
Enamine also offers synthesis of compounds from immediately accessible, validated chemical space (REAL DataBase)
of over 11,000,000 structures.
By application of drug-like and structural filters (Lipinski's and Veber's rules, MedChem filters) to our Screening Collection we have developed a Drug-Like library of 550 000 compounds. Targeted Libraries derived from Screening Collection are available separately, as well as Fragment-like library, containing over 300 original core heterocyclic fragments.
Our well-equipped laboratories, highly qualified personnel and vast scientific background enable us to challenge different custom synthesis tasks in mg/g/kg scale. Long term experience of our custom synthesis team (36 PhD’s) in synthesis of heterocyclic compounds, asymmetric and rigid compounds synthesis, transformations of organoelemental compounds facilitates progress of the most complex multi-stage projects.
Enamine's competitive pricing policy, top-level customer support and highest quality standards made it a promising partner for your outsourcing tasks.
Ukraine
